Sernova (TSE:SVA) Shares Down 1.5%

Sernova Corp. (TSE:SVAGet Free Report) shares traded down 1.5% on Thursday . The company traded as low as C$0.32 and last traded at C$0.34. 182,500 shares changed hands during trading, an increase of 17% from the average session volume of 156,507 shares. The stock had previously closed at C$0.34.

Analyst Upgrades and Downgrades

Separately, Raymond James set a C$1.50 price target on shares of Sernova and gave the company a “market perform” rating in a research note on Thursday, April 4th.

Check Out Our Latest Stock Report on SVA

Sernova Trading Down 1.5 %

The company has a market capitalization of C$101.64 million, a P/E ratio of -2.58 and a beta of 1.53. The business has a fifty day moving average of C$0.35 and a 200-day moving average of C$0.51. The company has a debt-to-equity ratio of 16.55, a quick ratio of 18.11 and a current ratio of 1.20.

About Sernova

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

Read More

Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.